InvestorPlace - Stock Market News, Stock Advice & Trading Tips
ATRA stock results show that Atara Biotherapeutics missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
The post ATRA Stock Earnings: Atara Biotherapeutics Misses EPS, Misses Revenue for Q4 2023 appeared first on InvestorPlace.
More From InvestorPlace